| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5954962 | Chest | 2015 | 9 Pages |
Abstract
Tiotropium resulted noninferiorly to salmeterol and superiorly to placebo in patients with moderate to severe asthma who were not adequately controlled by ICS or ICS/salmeterol. Major benefits were concentrated in the increase in lung function and in the case of patients with severe asthma, in the reduction of exacerbations.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Gustavo J. MD, José A. MD, PhD,